Addressing barriers in acute myeloid leukaemia care in India to improve outcomes and survival rates for patients.

Combination Achieved a 67% of Overall Response Rate, More than Double that of Zanubrutinib Alone; 83% Disease Control Rate in ...

A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

It can be hypothesized that in myeloid diseases, such as MDS, defects in cells that play a crucial role in orchestrating immune responses are highly relevant in the pathophysiology of the disease.

Leukemic stem cells (LSCs) and stemness signatures contribute to minimal residual disease in patients with acute myeloid leukemia (AML), which is associated with an increased risk of relapse. The ...

CUTTACK: Doctors at the clinical hematology department of SCB medical college and hospital here have successfully conducted ...

in acute myeloid leukemia (AML). Following this interim analysis triggered by 60 events (deaths) in the study population, the IDMC has recommended that the trial continue without modifications.

Detailed price information for Sellas Life Sciences Group Inc (SLS-Q) from The Globe and Mail including charting and trades.